RCT | Cancer stem cell assay-guided chemotherapy improves survival of patients with recurrent glioblastoma

Cancer stem cell assay-guided chemotherapy improves survival of patients with recurrent glioblastoma in a randomized trial – Cell Reports Medicine

News Release: ChemoID platform-predicted treatments lead to longer survival for glioblastoma patients – University of Cincinnati

Commentary on Twitter

Online now: Cancer stem cell assay-guided chemotherapy improves survival of patients with recurrent glioblastoma in a randomized trial https://t.co/y5GYCCgg3b

— Cell Reports Medicine (@CellRepMed) May 3, 2023